Concepedia

Kim Donckers

KD

Statistics

Publications

9

Citations

541

H-Index

9

Active since

2016

Affiliations

KU Leuven(Current)

Rega Institute for Medical Research

University of Bern

Leiden University Medical Center

Weizmann Institute of Science

Kim Donckers is an author at KU Leuven specializing in virology, immunology, and antiviral agents.

Top concepts

Publications per year

2016–2025

9

Publications

9

The Substitutions L50F, E166A, and L167F in SARS-CoV-2 3CLpro Are Selected by a Protease Inhibitor <i>In Vitro</i> and Confer Resistance To Nirmatrelvir

Dirk Jochmans, Kim Donckers, Antitsa Stoycheva et al. · mBio · 2023 · 163 citations · Full text

Open science discovery of potent noncovalent SARS-CoV-2 main protease inhibitors

Melissa L. Boby, D. Fearon, Matteo P. Ferla et al. · Science · 2023 · 158 citations · Full text

A robust SARS-CoV-2 replication model in primary human epithelial cells at the air liquid interface to assess antiviral agents

Thuc Nguyen Dan, Kim Donckers, Laura Vangeel et al. · Antiviral Research · 2021 · 64 citations · Full text

, , +16

The substitutions L50F, E166A and L167F in SARS-CoV-2 3CLpro are selected by a protease inhibitor <i>in vitro</i> and confer resistance to nirmatrelvir

Dirk Jochmans, Kim Donckers, Antitsa Stoycheva et al. · 2022 · 44 citations · Full text

Nirmatrelvir-resistant SARS-CoV-2 is efficiently transmitted in female Syrian hamsters and retains partial susceptibility to treatment

Rana Abdelnabi, Dirk Jochmans, Kim Donckers et al. · Nature Communications · 2023 · 26 citations · Full text

Rows per page

1–5 of 9